ETF Managers Group, LLC Seagen Inc. Transaction History

ETF Managers Group, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$108.81 - $179.33 $544,594 - $897,546	-5,005 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$119.61 - $157.85 $10,047 - $13,259	84 Added 1.71%	5,005 $709,000
Q4 2021 Feb 14, 2022	BUY	$142.57 - $190.86 $33,361 - $44,661	234 Added 4.99%	4,921 $774,000
Q3 2021 Nov 15, 2021	BUY	$142.45 - $169.82 $51,424 - $61,305	361 Added 8.34%	4,687 $770,000
Q2 2021 Aug 16, 2021	BUY	$135.08 - $161.1 $209,103 - $249,382	1,548 Added 55.72%	4,326 $686,000

Q1 2021 May 17, 2021	BUY	$137.51 - $190.8 $51,016 - $70,786	371 Added 15.41%	2,778 $382,000
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $396,264 - $510,115	2,407 New	2,407 $442,000

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of ETF Managers Group, LLC, based on Form 13F filings with the SEC.

Stay updated on ETF Managers Group, LLC with notifications on news.